Synapse - Natasha Rekhtman

Results (434)

SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors

Journal Article

Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation

Meeting Abstract

Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization

Meeting Abstract

Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
Cancer Research (2022)

Fulltext@MSK | Save

AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation

Meeting Abstract

Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; Egger, J.; Qiu, J.; more...
Cancer Research (2022)

Fulltext@MSK | Save

AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma

Meeting Abstract

Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Egger, J. V.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers

Meeting Abstract

DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Immune check-point inhibitor-related pneumonitis: Acute lung injury with rapid progression and organising pneumonia with less severe clinical disease

Journal Article

Imran, S.; Golden, A.; Feinstein, M.; Plodkowski, A.; Bodd, F.; Rekhtman, N.; Travis, W. D.; Stover, D. E.; Sauter, J. L.
Histopathology (2022)

Fulltext@MSK | Save

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Journal Article

Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
Nature Medicine (2022)

Fulltext@MSK | Save

Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset

Editorial

Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Small biopsy and cytology of pulmonary neuroendocrine neoplasms: Brief overview of classification, immunohistochemistry, molecular profiles, and World Health Organization updates

Review

Sung, S.; Heymann, J. J.; Politis, M. G.; Baine, M. K.; Rekhtman, N.; Saqi, A.
Advances in Anatomic Pathology (2022)

Fulltext@MSK | Save